Chemotherapy for lung cancer in Turkey: Best Clinics and Costs 2024

Professor Yesim Yıldırım has been working as a medical oncology specialist at Anadolu Medical Center since 2011. She is a member of the European Society of Medical Oncology (ESMO). She specializes in the cancer immunotherapy and targeted therapies, diagnostics and treatment of malignant neoplasms of various localizations, especially breast cancers, gastrointestinal cancers and lung cancers.  Also she wrote more than 80 international and national publications, abstracts and  books ( co-author in ‘Handbook of Advanced Cancer Care Treatment’ and ‘Precision medicine in cancer and non-communicable disease).  Yesim Yildirim is one of the outstanding specialists in the area of medical oncology. Not only a doctor, but also a scientist and lecturer in Halic University (Istanbul: Turkey). She is a member of several well-known associations: ESMO - European Society of Medical Oncology, ESO - European School of Oncology and so forth. Nowadays she is currently working in Anadolu Medical Centre at a position of Professor. Education: In 1999 Dr. Yesim Yıldırım graduated from  Hacettepe University Medical School and started internal medicine fellowship in Gazi University.  After finishing internal medicine she subsequently started her oncology career in Baskent University and became medical oncologist in 2007. During her academic  journey she was awarded by numbers of grants and scholarships. Academic experience:  Obtained a grade of minor assistant to the Medical Oncology Hospital Division after gaining a scholarship of Middle East Cancer Consortium and attending an advanced oncology tuition courses at Rambam Medical Centre in Haifa, Israel; In 2010 achieved an academic rank of Assistant Professor of internal diseases at Acibadem University School of Medicine; Gained the attestation certificate from ESMO examination (2010); Was conferred a scholastic Associate Professor degree in medical oncology after completing her academic studies in 2011; Participated to the training course in Melanoma and Kidney Cancer Clinic at Mount Vernon Cancer Center Immunooncology Clinic, London, UK;  Successfully finished MBA program in Healthcare Management in Bilgi University, Istanbul; In 2021 achieved an academic rank of Professor in Haliç University, Istanbul. Improving of practical qualification: Sivas Numune Hospital (compulsory service for government); Acibadem Kozyatagi Hospital; Acibadem University of Medicine; Anadolu Medical Centre, Istanbul, Turkey. Language: English, Russian (B1 level), Turkish

Mustafa Solak, M.D., who was born in 1978, was graduated from School of Medicine, Hacettepe University. He completed his residency education in İstanbul Sisli Etfal Teaching and Research Hospital and completed his fellowship in Cancer Institute of Hacettepe University.   He has dealt with many cases of Breast Cancer, Testicular Cancer, Ovarian Cancer, Lung Cancer, Head-Neck Cancer, Gastrointestinal Cancers.   FIELDS OF MEDICAL INTEREST Breast cancer Testicular Cancer Ovarian Cancer Lung Cancer Head & Neck Cancers Gastrointestinal cancers EDUCATİON: Bachelor's: Hacettepe University Faculty of Medicine Specialization: Istanbul Sisli Etfal Training and Research Hospital Minor Specialization: Hacettepe University Cancer Institute INSTITUTIONS WHERE EDUCATION AND WORKED The University of Texas MD Anderson Cancer Center Hitit University Corum Training Hospital Medical Park Hospital

Date of Birth: 08.28.1983 Nationality: Turkish About Experienced radiation oncologist proficient in overseeing oncology trends and achieving set goals, understanding marketplace needs and developing strategies with teamwork. Highlights of my experience include the following: • Starting oncology clinics from ground up. • Worked as manager and medical doctor at oncology clinics. • Arranged educations and educated oncology clinic staff. • Prepared official papers needed in clinic for medical devices and procedures. • Leading a technology start-up team and creating innovative strategies to boost profit.   Education-Experience 2015-2020.....MD, Radiation Oncologist, Bodrum Acibadem Hastanesi (Mugla) 2013-2015.....MD, Radiation Oncologist, M. Akif Inan Research Hospital (Sanliurfa) 2013..............MD Anderson Cancer Center Radiation Oncology Division (Houston Texas, USA) 2008-2013.....Residency, Ege University Hospital, Radiation Oncology Dept. (İzmir) 2001-2007.....Doctor of Medicine, Uludag University Medicine School (Bursa)   Language Turkish (native) English (fluent)   Areas of interest • Breast Cancer • Lung cancer • Prostate cancer • Rectal cancer • Head and neck cancers • Cervical cancer • Gastric cancer • Brain tumors   Detailed content of an Interest: Breast Cancer The uncontrolled and excessive proliferation of the cells that make up breast is called breast cancer. It is the most common cancer in women. Breast cancer is one of the most studied and most treatable cancer types by doctors. There are a wide variety of treatment methods available, depending on the progression of cancer. The chance of cure is higher in the early stages of cancer. In addition to surgical removal of cancerous tissue, very high success can be achieved with radiotherapy (radiation, radiation therapy) and chemotherapy (intravenous drugs). The administration of radiotherapy with the advanced technology devices and by experienced doctors will greatly reduce the side effects of radiotherapy and increase the patient's quality of life.   Attended Courses / Research Experience • Nanobiotechnology and Genetics in Oncology Research (Nov. 10-11, 2009. Antalya) • 5. National Oncology Research Symposium and Courses – TOGD (Nov. 12 15, 2009, Antalya • ESMO Course-Essentials of Medical Oncology (Feb. 3-7, 2010. Istanbul) • Current Approaches in Gynecologic Cancers (Feb. 20,2010 Istanbul) • Bioinformatics and Bionanotechnological Methods in Oncology (May. 5-6, 2010. Izmir) • Clinical Radiobiology Course, TROD (Oct. 15-16, 2010. Izmir) • Medical Radio Physics Course, TROD (Jun 3-4, 2011. Izmir) • Evidence-Based Radiation Oncology, ESTRO Course (Jun 28 – July 3, 2011. St. Petersburg-Russia) • Image-Guided Radiotherapy and Chemotherapy in Gynecological Cancer - Focus On Adaptive Brachytherapy, ESTRO Course (July 6-10, 2011, Izmir) • Varian Advanced Techniques Clinical School Stereotactic Radiotherapy (14-16 June 2017, Rome-Italy) • Varian Advanced Imaging (IGRT) Clinical School, (22–24 November, 2017, Amsterdam-Netherlands) Research & Publications · Özer Akgül, Hayriye Kırkoyun Uysal, İlker Tosun et al. PCR-based detection of intestinal protozoa in cancer and organ transplant recipient patients compared to a healthy control group. June 2020 International Journal of Clinical and Experimental Medicine 13(6):4434-4440 · Robotic Radiosurgery of Head and Neck Paragangliomas: A Single Institution Experience. Tosun İ1, Atalar B2,Şahin B2,Güngör G2,Aydin G2,Yapici B2,Özyar E2. Asia Pac J Clin Oncol.2017 May 24. Https://Doi.Org/10.1111/Ajco.12695 · Comparison Of Step-and-Shoot IMRT and Different Volumetric Modulated Arc Therapy (VMAT) Techniques for the Treatment Of Prostate Cancer - Oct. 28-31, 2012- 54. ASTRO Congress Poster Presentation, USA · Peritumoral Irradiation of Solid Tumors - Oral Presentation – Hypotheses Contest (Best Hypotheses) - 5. National Oncology Research Congress (Nov. 14 , 2009. Antalya) · Using Of Oxygen Molecule Binded Peptides as Radiotherapy Enhancers - Oral Presentation – Hypotheses Contest (Best Hypotheses)- 5. National Oncology Research Congress (Nov. 14 , 2009. Antalya) · The Effects Of Nonionizing Radiation on MicroRNAs- Oral Presentation + Poster Presentation. National Innovation Congress (Dec. 22 – 23, 2009. Albert Long Hall, Boğaziçi Univ., İstanbul) · Radionuclide bended Mesenchymal Stromal Cells in Cancer Diagnose and Treatment- Oral Presentation + Poster Presentation, National Innovation Congress (Dec. 22 – 23, 2009. Albert Long Hall, Boğaziçi Univ., İstanbul)   Professional Membership TROD (Turkish Society For Radiation Oncology) Turkish Medical Association MOKAD (Molecular Cancer Research Ass.) ESTRO (European Society for Therapeutic Radiology and Oncology) EACR (European Association for Cancer Research)